-
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trialDC Wheeler, BV Stefánsson, DAPA-CKD Trial Committees and Investigators et al. -
When high‐volume PCI operators in high‐volume hospitals move to lower volume hospitals—Do they still maintain high volume and quality of outcomes?Lu TH, Li ST, Yin WH et al.
-
Reappraisal of Reported Genes for Sudden Arrhythmic Death: An Evidence-Based Evaluation of Gene Validity for Brugada SyndromeS. Mohsen Hosseini, Raymond Kim, Sharmila Udupa
-
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries EndorsedV. Aboyans, J-B Ricco, M-L E. L. Bartelink et al
-
Coronary Artery Disease in Patients With Out-of-Hospital Refractory Ventricular Fibrillation Cardiac ArrestYannopoulos D, Bartos JA, Raveendran G et al.
-
Major trials in coronary intervention from 2018Patel A, Marah N, Balan P et al.
-
Coronary Artery Calcium Progression Is Associated With Coronary Plaque Volume Progression - Results From a Quantitative Semiautomated Coronary Artery Plaque AnalysisI Ceponiene, R Nakanishi, K Osawa et al.
-
Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and BeyondLibby P
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
